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Abstract  
Background: Targeted cancer therapies have played a great role in the treatment of malignant tumors, 
in the recent years. Among these therapies, targeted toxin therapies, immunotoxins, has improved the 
patient’s survival rate by minimizing the adverse effect on normal tissues, whereas delivering a high 
dose of tumoricidal agent for eradicating the cancer tissue. Immunologic proteins such as antibodies 
are conjugated to plant toxins or bacterial toxins such as Diphtheria toxin (DT) and Pseudomonas 
exotoxin A (PEA). In this case optimizing and expressing the Diphtheria toxin and Pseudomonas 
exotoxin A which their binding domains are eliminated plays a crucial role in producing the desired 
immunotoxin  
Materials and Methods: We expressed the truncated DT and PE toxin in a genetically modified E.coli 
strain BL21 (DE3). For this reason we eliminated the binding domain sequence of these toxins and 
expressed these proteins in an expression vector pET28a with the kanamycin resistant gene for 
selection. The optimization of the Diphtheria toxin and Pseudomonas exotoxin A expression were due 
to different IPTG concentration, induction and sonication time 
Results: We observed that the optimal protein expression was gained in 4 hours and at 25°C with 0.4 
mM IPTG concentration for DT and 4 hours and at 25°C with 0.5 mM IPTG concentration for PEA. 
Conclusion: Our study also showed lower IPTG concentrations could result in higher protein 
expression. By optimizing this procedure, we facilitate the protein production which could lead to 
accelerate the drug development  
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Introduction 
Cancer is one of the main reasons of death among the 
people worldwide and with its mysterious 
mechanisms it is almost inevitable to cure this 
malignant health problem without any adverse side 
effects1. In the recent years, targeted therapy is playing 
a major role in the treatment of malignant tumors2. 
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Targeted toxin therapies improve the patient’s 
survival rate by minimizing the adverse effect on 
normal tissues, whereas delivering a high dose of 
tumoricidal agent for eradicating the cancer tissue. 
Immunotoxins were invented for more selective 
binding of a specific toxin to the tumor cells. Two 
main parts of the immunotoxins are the targeting and 
killing compartments-. Immunologic proteins such as 
antibodies, growth factors or cytokines which help the 
immunotoxin to bind precisely to the target cells were 
conjugated to plant toxins such as ricin, abrin, 
mistletoe lectin or bacterial toxins such as Diphtheria 
toxin (DT) and Pseudomonas exotoxin A (PE)3-6. The 
potency of the immunotoxins comes from the toxin 
compartment whereas the specificity comes from the 
antibody or any other growth factors7. DT is a single 
chain protein with 535 amino acids comprising of 3 
functional groups:  A domain (amino acids 1-186) the 
catalytic domain, B domain (amino acids 389-535) the 
binding domain and the third domain is the 
transmembrane or the translocation domain (amino 
acids 187-388)8. The catalytic domain of DT inhibits 
the elongation factor 2 (eEF-2) by ADP-ribosylation 
of histidine-6999. This inhibition eliminates protein 
synthesis and induces cell apoptosis10. The role of the 
translocation domain is to internalize the toxin to the 
cytosol compartment4,11. The binding domain of the 
toxins is responsible for cell recognition and the 
attachment of the toxin to its cell receptor12,13. The 
single chain polypeptide of PE contains 613 amino 
acids comprising of 3 main domains. Ia domain is a 
binding domain, II domain is a translocation domain 
and the Ib domain which is a catalytic domain with the 
ADP-ribosylating activity which induces cell 
death14,15. 
In this study, we expressed truncated DT and PE 
toxins in a genetically modified E.coli strain BL21 
(DE3). For this reason, The binding domain sequences 
of these toxins was eliminated in order to specifically 
target the cancerous cells and expressed these proteins 
in an expression vector pET28a with the kanamycin 
resistant gene for selection. Moreover, we optimized 
the expression condition of the DT and PE toxins 




Bacterial strains and growth conditions: E. coli 
BL21 was used as host for the expression of truncated 
Diphtheria toxin and Pseudomonas exotoxin A. 
Cultures were grown in LB medium supplemented with 
kanamycin (50 µg/mL, Sigma). IPTG (SinaClone) was 
added to Luria Broth (LB) as an inducer. 
Gene design and vector construction: The protein 
sequences of Diphtheria toxin and Pseudomonas 
exotoxin A were searched at the Uniprot site. The 
binding domain sequences of these toxins were 
eliminated. The synthesis of pET28a expression vector 
encoding truncated DT and PE were ordered to 
Shinegene Company. The nucleotide sequences were 
optimized for E. coli codon usage. The optimized 
sequences of the toxins were subcloned with BamHI 
and XhoI into pET28a expression vector with 
kanamycin resistant gene. The finalized toxin 
sequences consisted of 379 amino acids (42 KD) for DT 
and 360 amino acids (40 KD) for PE. 
Transformation: The transformation of the expression 
vector pET28a to the E.coli bacteria BL21 (DE3) was 
fulfilled by incubating the bacteria with the expression 
vector comprising of the truncated diphtheria toxin and 
pseudomonas exotoxin A, separately, on ice for 30 
minutes and heat/shock treatment for 30 seconds. 250µl 
LB agar was added to the transformed bacteria and it 
was shacked for 45 minutes at 37°C. To form single 
bacteria colonies 50 µl of the transformed bacteria was 
placed on a LB agar plate with Kanamycin and it was 
incubated at 37°C overnight. Colonies, which grew up 
on the plate, were the ones with the pET vector 
containing the Kanamycin resistant gene. 
Diphtheria Toxin Production and Optimization: 
Each colony on the LB plate was inoculated in 10 ml 
LB Broth medium (0.2 gr LB Broth in 10 ml distilled 
water) with 10 µl Kanamycin and incubated for 16h at 
37°C in a bacterial shaker. 400 ml LB broth medium 
plus 400 µl Kanamycin was prepared after 16h of 
incubation for high yield production of the diphtheria 
toxin protein. 4 ml of the old medium was added to the 
400 ml LB Broth medium that makes 1% of the 
completely new medium. The optical density of the 
bacteria reached between 0.4 and 0.6 after 3 hours of 
incubating at 37°C in a bacterial shaker. Optimization 
of the protein expression is due to variable Isopropyl 
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(IPTG) concentrations, induction and sonication time. 
The bacteria were induced with 0.4, 0.6, 0.8 and 1 mM 
IPTG in different induction times of 2,4,6 and 8 hours 
at 2 different induction temperatures of 25 and 30°C. 
After inducing the bacteria with IPTG in the selected 
induction time and temperature, the solution was 
centrifuged at 4000 rpm for 15 min. The desired 
pellets of bacteria were dissolved in 8 ml of lysis 
buffer containing 50 mM Tris. Hcl (pH 8) and 150 mM 
Nacl. Finally the cells were sonicated on ice (10 × 15s) 
with 15s intervals and centrifuged at 5000 rpm for 20 
min at 4°C. The supernatant containing the proteins 
were stored at -20°C. 
Pseudomonas exotoxin A Production and 
Optimization: The procedures, which were done for 
the production and optimization of the Diphtheria 
toxin, were applied on Pseudomonas exotoxin A. In 
this case, the bacteria were induced with 0.5 and 1 mM 
IPTG in different incubation times of 2, 4, 6 and 8 
hours at 25°C and 30°C incubation temperatures.  
SDS-Page and western blot analysis: To obtain the 
best induction IPTG concentration, time and 
temperature, sodium dodecyl sulfate-polyacrylamide 
gel (SDS-PAGE) analysis was used. Proteins with 
different IPTG concentrations, time and temperatures 
were separated on a SDS-PAGE.  
Briefly, Protein samples were mixed with 5x loading 
buffer (0.5 M Tris, Glycerol, SDS, Bromophenolblue 
with 0.5% ethanol and 2-Mercaptoethanol) with 1:1 
ratio and boiled for 5 minutes just before loading and 
then equal amount of protein samples were subjected 
to 12% SDS-PAGE. Gels were analyzed by staining 
with Coomassie brilliant blue. The densities of protein 
bands were calculated using Image J software. Proof 
of Diphtheria toxin and Pseudomonas exotoxin A 
existence was done by western blotting analysis. For 
this matter, equal amount of protein samples were 
subjected to 12% SDS-PAGE and transferred to 
PVDF membranes. Then the blots were blocked 
overnight at 4°C in the blocking solution TBST 
(20mM Tris-Hcl pH 7.6, 100 mM NaCl and 0.1% 
tween) containing 3% skimmed milk and then 
incubated with anti his-tag HRP conjugated antibody 
diluted to 1:1500 in TBST with 1% skimmed milk. 
Our Diphtheria toxin and pseudomonas exotoxin A 
proteins were detected using an ECL western blotting 
kit followed by exposure to X-ray film. 
Results 
Cloning and sequencing of truncated DT and PE in 
expression vector: Diphtheria toxin and Pseudomonas 
exotoxin A binding domains were eliminated. The 
nucleotide and protein sequences of the truncated 
Diphtheria toxin were shown in figure 1 and 2 and 
truncated Pseudomonas exotoxin A sequences were 
shown in figure 3 and 4. The truncated Diphtheria toxin 
and Pseudomonas exotoxin A were cloned into a 
pET28a prokaryotic expression vector and transformed 
into E. coli BL21 (DE3). Formation of single bacteria 
colonies was due to overnight incubation at 37°C. 
Confirmation of bacteria colonies containing pET 28a 
vector with the truncated DT and PE gene were due to 
plasmid purification done by Vivantis Miniprep kit    
(Malaysia). DNA sequencing analysis confirmed 
 
 
Figure 1. Optimized DNA sequence of truncated DT. BamHI and 
Xho1 restriction sites, used for cloning in pET28a vector, are 




Figure 2. Protein sequence of truncated DT. Methionine followed 




Figure 3. Optimized DNA sequence of truncated PE. BamHI and 
Xho1 restriction sites, used for cloning in pET28a vector, are 
shown in bold. 
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constructed plasmid.  
Optimization of protein expression using different 
IPTG concentrations and induction time and 
temperature: Proteins with different IPTG induction 
concentrations, time and temperature were separated 
by SDS-pages. The densities of each desired protein 
bands were calculated using Image J software (USA). 
For truncated DT, we observed that the optimal 
protein expression was gained in 4h, 0.4 mM IPTG 
concentration at 25°C. The next best protein 
expression was observed in 4h, 0.6 mM IPTG 
concentration at 25°C. The expression ratios were 
calculated compared to control and presented below 
the figures (Figure 5; A-D). For truncated PE, we 
concluded that the best expression rate occurred in 0.5 
mM IPTG concentration no matter of time and 
temperature in comparison of 1mM IPTG 
concentration. In addition, we observed that the optimal 
protein expression was gained in 4h, 0.5 mM IPTG 
concentration at 25°C. The next best protein expression 
was observed in 2h, 0.5 mM IPTG concentration at 
25°C. The expression ratios were calculated compared 
to control and presented below the figures (Figure 7; A-
B). To confirm the identity of the Diphtheria toxin and 
Pseudomonas exotoxin A, western blot analysis was 
done with two best induction procedures. For DT 0.4 
and 0.6 mM IPTG concentrations after 4 hours of 
induction in 25°C (Figure 6) and for PE 0.5 mM IPTG 
concentrations after 2 and 4 hours in 25°C (Figure 8) 
showed two sharp bonds compared to control. 
Discussion 
Prokaryotic expression systems such as bacterial 
expression systems are desirable and economical 
 
 
Figure 4. Protein sequence of truncated PE. Methionine 




Figure 5. SDS-Page analysis of different protein expression levels in different IPTG concentrations, induction time and temperature. 1: 2h 
induction at 25˚C, 2: 2h induction at 30˚C, 3: 4h induction at 25˚C, 4: 4h induction at 30˚C, 5: 6h induction at 25˚C, 6: 6h induction at 30˚C, 
7: 8h induction at 25˚C, 8: 8h induction at 30˚C. 
(A) Diphtheria toxin expression levels in 0.4 mM IPTG concentration, 25˚C and 30˚C induction temperature and four different time inductions such 
as 2,4,6 and 8 hours. 
(B) Diphtheria toxin expression levels in 0.6 mM IPTG concentration, 25˚C and 30˚C induction temperature and four different time inductions such 
as 2,4,6 and 8 hours.   
(C) Diphtheria toxin expression levels in 0.8 mM IPTG concentration, 25˚C and 30˚C induction temperature and four different time inductions such 
as 2,4,6 and 8 hours.        
(D) Diphtheria toxin expression levels in 1 mM IPTG concentration, 25˚C and 30˚C induction temperature and four different time inductions such 
as 2,4,6 and 8 hours. 
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instruments in producing recombinant proteins such as 
toxins with no binding domain sequences16,17. E. coli 
is the most bacterial expression system used in 
producing recombinant proteins for its beneficial 
superiorities such as, simple high cell density efforts, 
easy exogenous DNA transformation and reasonable 
culture media18. E. coli BL21 (DE3) is a suitable strain 
for producing recombinant proteins because of its 
deficiency in coding protease genes that can degrade 
expressed proteins19,20. Induction temperature and 
incubation time are two most important factors that 
influence the protein expression in E. coli BL2121. 
25˚C and 30˚C induction temperatures are lower 
temperatures than 37˚C used in most protein expression 
protocols in order to reduce the inclusion body 
formations. In addition, higher temperatures could lead 
to plasmid loss19. Our results showed that 25˚C is the 
best induction temperature for expressing truncated DT 
and PE and the best induction temperature for reducing 
the inclusion body formations as inclusion bodies could 
lead to protein misfolding and malfunction. The other 
crucial factor that can influence the expression of the 
DT and PE proteins is the IPTG concentration. Ramirez 
et al, showed that low IPTG concentrations can lead to 
 
 
Figure 6. Western blots analysis of the two best induction procedures. Confirmation of Diphtheria toxin existence by western blot analysis. 




Figure 7. SDS-Page analysis of different protein expression levels in different IPTG concentrations, induction time and temperature for 
truncated PE.  2: 2h incubation for 25˚C  3: 4h incubation for 25˚C  4: 6h incubation for 25˚C 5: 8h  incubation in 25˚C 6: 2h incubation for 
30˚C  7: 4h incubation for 30˚C  8: 6h incubation for 30˚C  and 9: 8h incubation for 30˚C  . 
A: PE expression levels in 1 mM IPTG concentration, 25˚C and 30˚C induction temperature and four different time inductions such as 2,4,6 and 8 
hours. 
B. PE expression levels in 0.5 mM IPTG concentration, 25˚C and 30˚C induction temperature and four different time inductions such as 2,4,6 and 
8 hours. 
 
Amoozadeh et al.                                    Determining Induction Conditions for Expression of Truncated Diphtheria Toxin … 
NBM                                                                            136                                     Novelty in Biomedicine 2018, 3, 131-7 
lower protein yield and higher inducer concentrations 
can result in toxic effects20. Whereas our results 
showed that lower concentrations of IPTG such as 0.4 
mM for DT and 0.5 mM for PE has higher protein 
expression rates in contrast to higher IPTG 
concentrations, which would result in toxic effects, 
aligned with Ramirez studies. Overall, we investigated 
that the lower the induction temperature and inducer 
concentration the higher the recombinant protein 
expresses.  
On the other hand, high yield of functional 
recombinant protein synthesis has the key role in 
producing economical biopharmaceutical drugs. By 
optimizing this complex procedure, we will simplify 
the protein production which could accelerate the drug 
development21. 
Conclusion 
Accordingly, we present here the optimized condition 
for the production of truncated Diphtheria toxin and 
Pseudomonas exotoxin A in E.coli BL21 strain (DE3). 
We concluded that various IPTG concentrations in 
different induction times and temperatures vary the 
protein yield production and with SDS-Page method, 
at the end the best optimizing conditions were proved. 
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